XENE
Xenon Pharmaceuticals Inc.Healthcare$56.85
▼ Bearish
Mkt Cap: $5.43B|Float: 78.4M|SI: 7.0%|DTC: 2.6
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
149.7%
52W Range
$27-$64
ATR(14)
$2.06
Exp. Move
±7.1%
P/C Ratio
1.15
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
XENE Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $1.0M
- Max Pain
- $55.00
- Expected Move
- ±7.1%
- Put/Call OI
- 1.15
- Net Premium
- $-1.0M
- Spot Price
- $56.85
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$4.03 | ±7.1% | $52.82 | $60.87 |
| 2026-05-15 | 43 | ±$5.08 | ±8.9% | $51.77 | $61.92 |
| 2026-07-17 | 106 | ±$5.60 | ±9.8% | $51.25 | $62.45 |
| 2026-10-16 | 197 | ±$9.45 | ±16.6% | $47.40 | $66.30 |
| 2026-12-18 | 260 | ±$11.30 | ±19.9% | $45.55 | $68.15 |
| 2027-01-15 | 288 | ±$10.75 | ±18.9% | $46.10 | $67.60 |
Explore XENE options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.